化合物BD1047.2HBr T1740

Product Introduction
Bioactivity


英文名: BD-1047 dihydrobromide

描述: BD-1047 dihydrobromide (BD1047.2HBr) 是一种选择性的 sigma-1 receptor 受体拮抗剂，在预测精神分裂症疗效的动物模型中具有抗精神病活性。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 50 mg/mL (114.41 mM)


关键字: BD-1047 Dihydrobromide | BD-1047 | inhibit | Inhibitor | BD 1047 dihydrobromide | BD-1047 dihydrobromide | Sigma Receptor | BD 1047 Dihydrobromide | BD 1047 | BD1047 | BD1047 Dihydrobromide | BD1047 dihydrobromide

相关产品: WLB-89462 | BMY-14802 | NE-100 hydrochloride | 4-IBP | PD 144418 | BMY-14802 hydrochloride | 4-PPBP maleate | AD186 | Siramesine hydrochloride | Amitriptyline

相关库: Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Neuronal Signaling Compound Library | Inhibitor Library | GPCR Compound Library | Anti-Obesity Compound Library | Preclinical Compound Library | NO PAINS Compound Library | Bioactive Compound Library

化合物BD1047.2HBr T1740信息由TargetMol中国为您提供，如您想了解更多关于化合物BD1047.2HBr T1740报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途